K003261

Substantially Equivalent

CREATININE PLUS

Applicant: Roche Diagnostics Corp.
Product code: JFY
Advisory panel: Clinical Chemistry
Date received: 2000-10-18
Decision date: 2000-11-16
Decision: Substantially Equivalent
Clearance type: Special
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.